NCT01468506

Brief Summary

The purpose of this study is to analyze and identify pre-, intra-, and post- operative parameters that predict Steal-Syndrome with distal malperfusion after Arterio-Venous Fistulas (AVF) as primary endpoint. Secondary endpoints are pre-, intra-, and post- operative parameters that predict patency and fistula maturation.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 3, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 9, 2011

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

September 25, 2014

Status Verified

September 1, 2014

Enrollment Period

3 years

First QC Date

November 3, 2011

Last Update Submit

September 23, 2014

Conditions

Keywords

Chronic Kidney Diseasearteriovenous fistula

Outcome Measures

Primary Outcomes (1)

  • Steal-Syndrome

    Steal Syndrome as defined according to the guidelines of the Society of Vascular Surgery (SVS): Asymptomatic (pulse deficits, doppler signal attenuation, and distal flow reversal) Mild Ischemia: slight coldness and numbness that occurs only during dialysis, may be self-limited, and may resosolve without treatment, and Severe Ischemia: Can be permanent and may be associated with constant pain, severe numbness, digital cyanosis or gangrene, finger contracture, or amputation of a digit hand or forearm. Standard assessment for steal syndrom at 5-10 days, 4-6 weeks, 6 months, and 1 year.

    1 year

Secondary Outcomes (2)

  • Time to fistula maturation

    1 year

  • Fistula patency

    1 year

Study Arms (1)

Fistula patients

Consecutive patients with autogenous, brachio-cephalic, brachio-basilic or brachio-brachial arterio-venous fistula creation for hemodialysis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients selected for this protocol must have the necessity to undergo surgery to receive an Arterio-Venos Fistula (AVF) for hemodialysis in either arm.

You may qualify if:

  • Patients 18 years of age
  • Autogenous, brachio-cephalic, brachio-basilic or brachio-brachial Arterio- Venous Fistula creation for hemodialysis
  • General preoperative requirements for this surgery passed
  • Patients willing to adhere to the follow-up
  • Patients able to understand and provide informed consent

You may not qualify if:

  • Less than 18 years of age
  • Patient is unable or unwilling to provide consent
  • Prosthetic graft creation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute

Miami, Florida, 33176, United States

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicArteriovenous Fistula

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsArteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, Anatomical

Study Officials

  • Athanassios Tsoukas, MD

    Baptist Hospital Miami, BCVI

    PRINCIPAL INVESTIGATOR
  • Heiko Uthoff, MD

    Baptist Hospital Miami, BCVI

    PRINCIPAL INVESTIGATOR
  • Philipp Geisbuesch, MD

    Baptist Hospital Miami, BCVI

    PRINCIPAL INVESTIGATOR
  • Raul Herrera, MD

    Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute

    STUDY DIRECTOR
  • Barry Katzen, MD

    Medical Director Baptist Cardiac and Vascular Institute

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Clinical Research, Baptist Hospital of Miami, BCVI

Study Record Dates

First Submitted

November 3, 2011

First Posted

November 9, 2011

Study Start

September 1, 2011

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

September 25, 2014

Record last verified: 2014-09

Locations